The effect of canagliflozin on renal function in elderly patients with type 2 diabetes who retained cardiac function (Sub-analysis of the Canonical Study)

The effect of canagliflozin on renal function in elderly patients with type 2 diabetes who retained cardiac function (Sub-analysis of the Canonical Study) - Canonical Sub-analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061247

Enrollment

Registered

2026-04-20

Start date

2026-04-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly (65 years or older) patients with type 2 diabetes and HFpEF

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Total study participants of the CANONICAL study (82 people) 42 patients in Canaglu group, 40 patients in standard treatment group

Exclusion criteria

Exclusion criteria: A person with missing data for all anemia markers related to renal anemia (Hb, Ht, RBC-count, MCV, MCH) and renal function markers (eGFR).

Design outcomes

Primary

Measure	Time frame
Anemia markers (Hb) related to renal anemia	—

Countries

Japan

Contacts

Public ContactShimazu Koki

Nara Medical University Hospital Clinical Research Center

shimkoki-aran@naramed-u.ac.jp0744-22-3051

Outcome results